The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1276 participants.
Also called NCT04559945
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,276 participants
- Sponsor
- Registry
-
NCT04559945
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Czechia, France, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04559945. Allocation not applicable; no masking; primary purpose treatment. Start 2020-11-13 (actual); primary completion 2022-07-18 (actual). Results posted on 2026-05-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
- Condition
- Cardiac Rhythm Disorder
- Condition
- Bradycardia
- Intervention (Device)
- Aveir VR Leadless Pacemaker System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04559945- Content hash
d15d5b4898d3af257a69246e37e5bce0504a53cc4080df9bc12f1a7f3fd97a5e